Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 11, 1998, Pages 3000-3001

  Piccolomini, R ^a   Catamo, G ^a   Di Bonaventura, G ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERIODONTITIS; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0031785550     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.11.3000     Document Type: Article

References (19)

1. Asikainen, S., H. Jousimies-Somer, A. Kanervo, and L. Saxén. 1990. The immediate efficacy of adjunctive doxycycline in treatment of localized juvenile periodontitis. Arch. Oral Biol. 35:231S-234S.
2. Chan, E. C. S., W. Al-Joburi, S.-L. Cheng, and F. Delorme. 1989. In vitro susceptibilities of oral bacterial isolates to spiramycin. Antimicrob. Agents Chemother. 33:2016-2018.
3. Christersson, L. A., J. Slots, J. J. Zambon, and R. J. Genco. 1985. Transmission and colonization of Actinobacillus actinomycetemcomitans in localized juvenile periodontitis patients. J. Periodontol. 56:127-131.
4. Goldstein, E. J. C., D. M. Citron, A. E. Vagvolgyi, and S. M. Finegold. 1986. Susceptibility of bite wound bacteria to seven oral antimicrobial agents, including RU-985, a new erythromycin: considerations in choosing empiric therapy. Antimicrob. Agents Chemother. 29:556-559.
5. Jorgensen, J. H., A. W. Howell, and L. A. Maher. 1990. Antimicrobial susceptibility testing of less commonly isolated Haemophilus species using Haemophilus test medium. J. Clin. Microbiol. 28:985-988.
6. Jousimies-Somer, H., S. Asikainen, P. Soumala, and P. Summanen. 1988. Activity of metronidazole and its hydroxy metabolite against clinical isolates of Actinobacillus actinomycetemcomitans. Oral Microbiol. Immunol. 3:32-34.
7. Kees, F., M. Wellenhofer, and H. Grobecker. 1995. Serum and cellular pharmacokinetics of clarithromycin 500 mg q.d. and 250 mg b.i.d. in volunteers. Infection 23:168-172.
8. Mandell, R. L., L. S. Tripoli, E. Savitt, M. Goodson, and S. S. Socransky. 1986. The effect of treatment on Actinabacillus actinomycetemcomitans in localized juvenile periodontitis. J. Periodontol. 57:94-99.
9. Mintz, K. P., and P. M. Fives-Taylor. 1994. Adhesion of Actinobacillus actinomycetemcomitants to a human oral cell line. Infect. Immun. 62:3672-3678.
10. Miyake, Y., K. Tsuruda, K. Okuda, Y. Iwamoto, and H. Suginaka. 1995. In vitro activity of tetracyclines, macrolides, quinolones, clindamycin, and metronidazole against periodontopathic bacteria. J. Periodontal Res. 30:290-293.
11. National Committee for Clinical Laboratory Standards. 1995. Approved standard M7-A3. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards, Villanova, Pa.
12. Pajukanta, R., S. Asikainen, M. Saarela, S. Alaluusua, and H. Jousimies-Somer. 1992. In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans. Antimicrob. Agents Chemother. 36:1241-1243.
13. Piccolomini, R., G. Di Bonaventura, G. Catamo, C. Picciani, and M. Paolantonio. 1997. In vitro antimicrobial susceptibility of periodontopathic Actinobacillus actinomycetemcomitans to roxithromycin and erythromycin. Oral Microbiol. Immunol. 12:366-371.
14. Piccolomini, R., G. Catamo, G. Di Bonaventura, C. Picciani, and M. Paolantonio. 1998. Laboratory and clinical comparison of preservation media and transport conditions for survival of Actinobacillus actinomycetemcomitans. J. Med. Microbiol. 47:743-748.
15. Piccolomini, R., G. Di Bonaventura, G. Catamo, and M. Neri. 1998. In vitro activity of clarithromycin against intracellular Helicobacter pylori, abstr. 7.09. In Program and abstracts of the 4th International Conference on the Macrolides, Azalides, Streptogramins and Ketolides (ICMASK IV), Barcelona, Spain.
16. Scaglione, F., G. Demartini, S. Dugnani, and F. Fraschini. 1993. A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells. Chemotherapy (Basel) 39:416-423.
17. Slots, J. 1982. Selective medium for isolation of Actinobacillus actinomycetemcomitans. J. Clin. Microbiol. 15:606-609.
18. Walker, C. B., K. T. Tyler, S. B. Low, and C. J. King. 1987. Penicillin-degrading enzymes associated with adult periodontitis. Oral Microbiol. Immunol. 2:129-131.
19. Zambon, J. J., T. Umemoto, E. De Nardin, E. Z. Nakazawa, L. A. Christersson, and R. J. Genco. 1988. Actinobacillus actinomycetemcomitans in the pathogenesis of human periodontal disease. Adv. Dent. Res. 2:269-274.